HCMA RECOGNIZED CENTER OF EXCELLENCE

Owner

Goods & Services

Promoting public awareness of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Promoting public interest and awareness of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Charitable services, namely, promoting public awareness of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Arranging and conducting of volunteer programs and community service projects for charitable purposes; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis

Printed educational course materials in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed magazine columns about hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed general feature magazines in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed magazines in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed materials, namely, journals featuring hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed journals in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed informational flyers featuring hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed diagrams for hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis